Emisphere’s drug delivery platform, known as the Eligen Technology, uses proprietary, synthetic carriers to enhance the oral bioavailability of a drug without altering its chemical form or biological
DPT Laboratories said that these centers of excellence concentrate on sterile & specialty products, semi-solids & liquids and research & development to support clients’ pharmaceutical development programs and
Nilodor, is expected to distribute SpectraSan 24 to more than 1800 sales and distribution partners around the country. BioTech Medical claimed that unlike traditional alcohol or bleach-based surface
The announcement follows the recent expansion of Icon’s operations in Seoul, Korea and Icon Central Laboratories’ move to a larger laboratory facility in Singapore. Reportedly, Icon has conducted
The agency’s warning letters require Glenmark and Konec to remove the unapproved tablets as part of the FDA’s Unapproved Drugs Initiative. The initiative was announced in 2006 to
Operating income was RMB26.67m, compared to RMB24.25m for the prior year period. China Nuokang has posted a net income of RMB23.45m, or RMB0.18 per diluted share, an increase
Key features of the unit include access to special population like young women, post-menopausal women, diseased population and access to about 12,000 healthy volunteers. GVK BIO’s Clinical Pharmacology
LCZ696 is a novel-acting compound with distinctive chemical and biological properties; upon oral administration, it simultaneously inhibits both NEP and the angiotensin receptor. By targeting these two neurohormonal
Dishman Pharma, through synthetic chemistry research, has developed manufacturing processes for various intermediates, APIs, quarternary ammonium compounds (QUATS) and specialty chemicals. Dishman is a global outsourcing partner for
The Phase 3 study is an 18-month randomised, parallel group, double-blind, placebo controlled trial evaluating the efficacy and safety of Olesoxime against placebo in patients diagnosed with ALS
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.